Applied DNA Sciences Inc
NASDAQ:APDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yamato Industry Co Ltd
TSE:7886
|
JP |
|
S
|
Stelco Holdings Inc
OTC:STZHF
|
CA |
|
clearvise AG
XETRA:ABO
|
DE |
|
R
|
RioCan Real Estate Investment Trust
F:R7G
|
CA |
|
S
|
Sinnar Bidi Udyog Ltd
BSE:509887
|
IN |
|
Technical Communications Corp
OTC:TCCO
|
US |
|
C
|
China Oilfield Services Ltd
HKEX:2883
|
CN |
|
A
|
Accent Resources NL
ASX:ACS
|
AU |
Applied DNA Sciences Inc
Goodwill
Applied DNA Sciences Inc
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Applied DNA Sciences Inc
NASDAQ:APDN
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Goodwill
$49.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Danaher Corp
NYSE:DHR
|
Goodwill
$43.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Waters Corp
NYSE:WAT
|
Goodwill
$1.3B
|
CAGR 3-Years
46%
|
CAGR 5-Years
25%
|
CAGR 10-Years
14%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Goodwill
$4.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Goodwill
$16.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
37%
|
|
Applied DNA Sciences Inc
Glance View
Applied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. The company is headquartered in Stony Brook, New York and currently employs 78 full-time employees. The company went IPO on 2001-08-24. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. Applied DNA also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
